Form 6-K Mind Medicine (MindMed) For: Nov 12

Press/Media: Public EngagementPopular

Description

MIND MEDICINE (MINDMED) INC. On January 12, 2021, the Company announced an LSD study evaluating the potential benefits of LSD on cognitive performance, sleep quality, mood, neuroplasticity markers, emotion regulation, quality of life and immune system response. The study will be conducted in collaboration with Dr. Kim Kuypers of Maastricht University in the Netherlands, a global, leading authority ...

Period12 Nov 2021

Media coverage

1

Media coverage

  • TitleForm 6-K Mind Medicine (MindMed) For: Nov 12
    Degree of recognitionInternational
    Media name/outletStreetInsider
    Media typeWeb
    Country/TerritoryUnited States
    Date12/11/21
    DescriptionMIND MEDICINE (MINDMED) INC. On January 12, 2021, the Company announced an LSD study evaluating the potential benefits of LSD on cognitive performance, sleep quality, mood, neuroplasticity markers, emotion regulation, quality of life and immune system response. The study will be conducted in collaboration with Dr. Kim Kuypers of Maastricht University in the Netherlands, a global, leading authority ...
    Producer/AuthorMind Medicine
    URLhttps://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Mind+Medicine+%28MindMed%29+++For%3A+Nov+12/19206799.html
    PersonsKim Kuypers